 |
|
|
|
 |
|
|
| Article 1 to 10 out of 31 concerning Sigma-Aldrich Corp.
|
-
Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
(28 Feb 2008)
AbD Serotec will use proprietary technology to generate antibodies against novel research targets provided by Sigma-Aldrich
Sigma-Aldrich and MorphoSys AG announced a collaboration agreement to design, produce and distribute unique recombinant research antibodies using MorphoSys's proprietary HuCAL GOLD(R) technology. MorphoSys's AbD Serotec unit will develop and qualify ...
-
Oxford Biomedica and Sigma-Aldrich win key ruling in open biosystems patent infringement dispute
(29 Oct 2007)
Oxford BioMedica and Sigma-Aldrich announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich. The ruling was part ...
-
Sigma-Aldrich and Sangamo BioSciences Announce Alliance to Develop Zinc Finger-Based Laboratory Research Reagents
(13 Jul 2007)
Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. announced a significant alliance focused on the development of high value laboratory research reagents based upon Sangamo's ZFP technology. The alliance combines Sigma's global marketing ...
-
SAFC Completes Construction of Major New Protein Purification Facility
(27 Apr 2007)
SAFC, a member of the Sigma-Aldrich Group, has announced the construction completion of two major new protein API facilities at its St. Louis, Missouri manufacturing campus.A new Biologics manufacturing facility consists of a 25,000 sq. ft. cGMP ...
-
Sigma-Proligo Expands Into Genopole(R) d'Evry Biopark
(20 Oct 2006)
Sigma-Proligo, a division of the Sigma-Aldrich group (Nasdaq: SIAL), announced it has acquired 2,000 sq. meters of office space in the heart of the Genopole(R) d'Evry biopark in the region of Paris. Sigma- Proligo has 65 employees in France, the ...
-
SAFC Bangalore Medicinal Chemistry Facility Opens in India
(09 Oct 2006)
SAFC, a member of the Sigma-Aldrich Group, announced its Pharma business segment's medicinal chemistry facility located in Bangalore, India, is ready for operation. The 139,000 sq. ft. facility represents a $12 million investment and is considered a ...
-
Sigma-Aldrich Welcomes the University of Edinburgh to the RNAi Partnership Program
(06 Oct 2006)
Sigma-Aldrich, a member of The RNAi Consortium (TRC) proudly welcomes the University of Edinburgh to the RNAi Partnership Program. As the newest member of the RNAi Partnership Program, the University of Edinburgh gains access to cutting-edge ...
-
Sigma-Genosys Installs New Systems for Its Fast Growing Custom Peptide Services
(14 Jul 2006)
Sigma-Genosys, a division of Sigma-Aldrich announced that it has expanded its portfolio of technologies to support its rapidly growing custom peptide business.Central to this expansion is the introduction of mass-based purification systems. LC/MS ...
-
Sigma-Aldrich and Oxford BioMedica Pursue Protection of RNAi-Related Intellectual Property; File Suit Against Open Biosystems
(15 Jun 2006)
Sigma-Aldrich and Oxford BioMedica have announced that they have filed a lawsuit against Open Biosystems, Inc. for infringement of key patents that cover key lentiviral-based systems for delivery of foreign DNA to a broad array of mammalian cells. ...
-
Sigma-Aldrich Announces Service Provider for Whole Genome Amplification Technology
(06 Jun 2006)
Sigma-Aldrich announced MOgene, LC as its first service provider of the GenomePlex® Whole Genome Amplification (WGA) technology. This follows a recent licensing agreement with Rubicon Genomics, allowing Sigma to offer GenomePlex Whole Genome ...
|
|
|
|
|
Top
